Etanercept changes

From 1 November, authority requirements regarding etanercept for the treatment of children and adolescents with severe chronic plaque psoriasis will change The Pharmaceutical Benefits Advisory Committee’s recommendations led to the changes, which will see PBS listings for initial therapy change from Authority Required (Written) to Authority Required (telephone/immediate online assessment). The PBS listings to complete a

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous Eight weeks to secure 8CPA
Next Unapproved hay fever product could contain botox